Robust use of phenotypic heterogeneity at drug target genes for mechanistic insights: Application of cis‐multivariable Mendelian randomization to GLP1R gene region
Open Access
- 20 February 2024
- journal article
- research article
- Published by Wiley in Genetic Epidemiology
- Vol. 48 (4) , 151-163
Abstract
Phenotypic heterogeneity at genomic loci encoding drug targets can be exploited by multivariable Mendelian randomization to provide insight into the pathways by which pharmacological interventions may affect disease risk. However, statistical inference in such investigations may be poor if overdispersion heterogeneity in measured genetic associations is unaccounted for. In this work, we first develop conditional F statistics for dimension‐reduced genetic associations that enable more accurate measurement of phenotypic heterogeneity. We then develop a novel extension for two‐sample multivariable Mendelian randomization that accounts for overdispersion heterogeneity in dimension‐reduced genetic associations. Our empirical focus is to use genetic variants in the GLP1R gene region to understand the mechanism by which GLP1R agonism affects coronary artery disease (CAD) risk. Colocalization analyses indicate that distinct variants in the GLP1R gene region are associated with body mass index and type 2 diabetes (T2D). Multivariable Mendelian randomization analyses that were corrected for overdispersion heterogeneity suggest that bodyweight lowering rather than T2D liability lowering effects of GLP1R agonism are more likely contributing to reduced CAD risk. Tissue‐specific analyses prioritized brain tissue as the most likely to be relevant for CAD risk, of the tissues considered. We hope the multivariable Mendelian randomization approach illustrated here is widely applicable to better understand mechanisms linking drug targets to diseases outcomes, and hence to guide drug development efforts.Keywords
This publication has 47 references indexed in Scilit:
- Using genetic association data to guide drug discovery and development: Review of methods and applicationsThe American Journal of Human Genetics, 2023
- Disentangling the effects of traits with shared clustered genetic predictors using multivariable Mendelian randomizationGenetic Epidemiology, 2022
- Testing and correcting for weak and pleiotropic instruments in two‐sample multivariable Mendelian randomizationStatistics in Medicine, 2021
- Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and designAmerican Heart Journal, 2020
- Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trialsDiabetes & Metabolism, 2019
- Mendelian randomization with fine‐mapped genetic data: Choosing from large numbers of correlated instrumental variablesGenetic Epidemiology, 2017
- 10 Years of GWAS Discovery: Biology, Function, and TranslationThe American Journal of Human Genetics, 2017
- The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex DiseaseCell, 2016
- Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized DataGenetic Epidemiology, 2013
- Identical mutations and phenotypic variationHuman Genetics, 1997